Pharvaris N.V. Files 2023 Annual Report

Ticker: PHVS · Form: 20-F · Filed: 2024-04-10T00:00:00.000Z

Sentiment: neutral

Topics: annual-report, financials, pharmaceutical

TL;DR

Pharvaris 20-F is out, detailing 2023 financials. Check it for key numbers and risks.

AI Summary

Pharvaris N.V. filed its 20-F for the fiscal year ending December 31, 2023. The company, a pharmaceutical preparations firm, reported financial data including accumulated depreciation and amortization, other reserves, and interest rate risk. Key financial figures and operational details are presented in this annual report.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Pharvaris N.V.'s financial performance and position for the fiscal year 2023, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Pharvaris is subject to significant regulatory, clinical trial, and market risks inherent in drug development and commercialization.

Key Numbers

42,730,779 — FY (Likely represents a financial figure for the fiscal year, though the specific metric is not detailed in the provided snippet.)

Key Players & Entities

Pharvaris N.V. (company) — Filer of the 20-F report
20231231 (date) — Fiscal year end date for the report
2834 (dollar_amount) — Standard Industrial Classification code for Pharmaceutical Preparations
0000950170-24-043358 (company) — Accession number for the filing

FAQ

What is the primary business of Pharvaris N.V. as indicated by its SIC code?

Pharvaris N.V.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

What is the fiscal year end date for the 20-F filing?

The Conformed Period of Report is 20231231, indicating the fiscal year ends on December 31, 2023.

What is the filing date of this 20-F report?

The filing date (FILED AS OF DATE) is 20240410.

What are some of the financial statement members mentioned in the filing data?

The filing data mentions members such as AccumulatedDepreciationAndAmortisationMember, OtherReservesMember, InterestRateRiskMember, and SharePremiumMember.

What was Pharvaris N.V.'s former company name and when did the name change occur?

The former company name was Pharvaris, B.V., and the date of the name change was 20201029.

From the Filing

0000950170-24-043358.txt : 20240410 0000950170-24-043358.hdr.sgml : 20240410 20240410161231 ACCESSION NUMBER: 0000950170-24-043358 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 118 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 24835912 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 20-F 1 phvs-20231231.htm 20-F 20-F false 0001830487 FY 42,730,779 0001830487 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2021-12-31 0001830487 ifrs-full:OtherReservesMember 2022-01-01 2022-12-31 0001830487 ifrs-full:InterestRateRiskMember 2023-12-31 0001830487 2023-06-30 0001830487 phvs:OtherAccruedLiabilitiesMember 2022-12-31 0001830487 phvs:FixedAssetsMember 2022-12-31 0001830487 phvs:IntellectualPropertyCostsMember 2023-01-01 2023-12-31 0001830487 phvs:ShareOptionsVestingMember 2022-04-01 2022-04-01 0001830487 phvs:BlackScholesFormulaMember 2021-07-01 2021-07-01 0001830487 ifrs-full:BottomOfRangeMember 2022-12-31 0001830487 ifrs-full:SharePremiumMember 2022-01-01 2022-12-31 0001830487 country:CH phvs:TaxYear2029Member 2023-01-01 2023-12-31 0001830487 ifrs-full:IssuedCapitalMember 2021-12-31 0001830487 ifrs-full:OtherReservesMember 2021-01-01 2021-12-31 0001830487 ifrs-full:SharePremiumMember 2023-12-31 0001830487 2023-12-31 0001830487 phvs:BlackScholesFormulaMember 2022-01-01 2022-01-01 0001830487 phvs:GuaranteeMember 2023-12-31 0001830487 phvs:BlackScholesFormulaMember 2022-04-01 0001830487 phvs:ShareOptionsVestingMember 2022-01-01 2022-01-01 0001830487 phvs:BlackScholesFormulaMember 2022-01-01 0001830487 ifrs-full:TopOfRangeMember ifrs-full:OfficeEquipmentMember 2023-01-01 2023-12-31 0001830487 phvs:NonCurrentProvisionsAndLiabilitiesMember 2021-12-31 0001830487 country:NL phvs:TaxYear2029Member 2023-01-01 2023-12-31 0001830487 ifrs-full:SharePremiumMember 2021-12-31 0001830487 phvs:ShareOptionsVestingMember 2021-07-01 2021-07-01 0001830487 phvs:OptionOneMember phvs:BlackScholesFormulaMember 2021-06-25 2021-06-25 0001830487 phvs:NonCurrentProvisionsAndLiabilitiesMember 2022-12-31 0001830487 ifrs-full:CurrencyRiskMember 2021-01-01 2021-12-31 0001830487 phvs:OptionOneMember phvs:BlackScholesFormulaMember 2021-06-25 0001830487 ifrs-full:TopOfRangeMember 2023-12-31 0001830487 phvs:ResearchAndDevelopmentExpensesMember 2023-12-31 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember phvs:ExercisePriceOf1814PerShareMember 2022-04-01 2022-04-01 0001830487 ifrs-full:SharePremiumMember 2022-12-31 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-12-31 0001830487 phvs:PharvarisIncMember 2023-01-01 2023-12-31 0001830487 phvs:BlackScholesFormulaMember 2023-11-15 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2021-12-31 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2022-04-01 2022-04-01 0001830487 phvs:ClinicalExpensesMember 2021-01-01 2021-12-31 0001830487 ifrs-full:UnusedTaxLossesMember phvs:UnlimitedMember 2023-01-01 2023-12-31 0001830487 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001830487 2022-01-01 2022-03-31 0001830487 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001830487 ifrs-full:TopOfRangeMember 2021-12-31 0001830487 ifrs-full:RetainedEarningsMember 2021-12-31 0001830487 phvs:TaxYear2028Member ifrs-full:UnusedTaxLossesMember 2023-01-01 2023-12-31 0001830487 2